There is no drug known as "Tab olmesartan." It is possible that "Tab" is a typo or a misunderstanding, and the intended query refers to olmesartan medoxomil, an angiotensin II receptor blocker (ARB) commonly prescribed to treat high blood pressure [1]. Olmesartan medoxomil is available under various brand names, including Benicar, Benicar HCT (in combination with hydrochlorothiazide), Olmetec, and Resplenon [2].
What is Olmesartan Medoxomil Used For?
Olmesartan medoxomil is primarily prescribed to manage hypertension, or high blood pressure [1]. By blocking the action of angiotensin II, a substance in the body that narrows blood vessels, olmesartan medoxomil helps to relax these vessels, leading to a reduction in blood pressure [3]. It is also used in combination with other medications, such as hydrochlorothiazide, to achieve better blood pressure control [2].
How Does Olmesartan Work?
Olmesartan medoxomil belongs to a class of drugs called angiotensin II receptor blockers (ARBs) [1]. Angiotensin II is a potent vasoconstrictor, meaning it causes blood vessels to narrow. It also stimulates the release of aldosterone, a hormone that causes the body to retain sodium and water, further increasing blood pressure. Olmesartan medoxomil works by selectively blocking the binding of angiotensin II to its receptor (AT1 receptor) found in vascular smooth muscle and the adrenal gland. This blockade prevents the vasoconstrictive and aldosterone-secreting effects of angiotensin II, resulting in vasodilation and reduced sodium and water retention, thereby lowering blood pressure [3].
When Does Olmesartan Medoxomil Go Off-Patent?
Patent expiry dates for pharmaceuticals are complex and can vary by region and specific patent. DrugPatentWatch.com provides detailed patent information, including expiry dates, for various medications [4]. For olmesartan medoxomil, generic versions have become available in many markets after the expiry of key patents. For instance, in the United States, the patent for Benicar expired, allowing for the introduction of generic olmesartan medoxomil [5]. It is advisable to consult DrugPatentWatch.com for the most precise and up-to-date patent status for olmesartan medoxomil in specific geographic regions [4].
Who Makes Generic Olmesartan Medoxomil?
Following the expiry of original patents, numerous pharmaceutical companies have begun manufacturing and marketing generic versions of olmesartan medoxomil. These manufacturers include companies like Teva Pharmaceuticals, Mylan N.V., and Aurobindo Pharma, among others [6]. The availability of generics typically leads to a decrease in the cost of the medication.
What are the Side Effects of Olmesartan Medoxomil?
Common side effects associated with olmesartan medoxomil can include dizziness, lightheadedness, headache, and fatigue [7]. Some individuals may experience gastrointestinal issues such as nausea or diarrhea. A rare but serious side effect associated with ARBs, including olmesartan medoxomil, is severe diarrhea that can lead to significant weight loss and dehydration, known as sprue-like enteropathy [8]. Patients experiencing persistent or concerning side effects should consult their healthcare provider.
What is the Difference Between Olmesartan and Benicar?
Benicar is a brand name for olmesartan medoxomil, manufactured by Daiichi Sankyo and AstraZeneca [2]. Olmesartan medoxomil is the active pharmaceutical ingredient. Therefore, Benicar is a specific brand of olmesartan medoxomil. Generic versions of olmesartan medoxomil are available under the drug's generic name and are produced by various pharmaceutical companies [6].
Can Patients Switch to Generic Olmesartan Medoxomil?
Patients can typically switch to generic olmesartan medoxomil once the original patents have expired and generic versions are approved and available in their region [5]. Generic medications are required to be bioequivalent to their brand-name counterparts, meaning they contain the same active ingredient and are absorbed by the body in the same way. Healthcare providers usually approve such switches, as generic olmesartan medoxomil offers the same therapeutic benefits at a lower cost [6].
---
Sources:
1. https://www.drugpatentwatch.com/drug/olmesartan-medoxomil
2. https://www.drugpatentwatch.com/brand/benicar
3. https://www.drugpatentwatch.com/mechanism-of-action/olmesartan-medoxomil
4. https://www.drugpatentwatch.com/
5. https://www.drugpatentwatch.com/country/US/drug/olmesartan-medoxomil
6. https://www.drugpatentwatch.com/generic/olmesartan-medoxomil
7. https://www.drugpatentwatch.com/side-effects/olmesartan-medoxomil
8. https://www.drugpatentwatch.com/adverse-events/sprue-like-enteropathy